Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 856967, 6 pages
http://dx.doi.org/10.1155/2013/856967
Research Article

Isotretinoin Oil-Based Capsule Formulation Optimization

1Department of Business Administration, I-Shou University, No. 1, Section 1, Syuecheng Road, Dashu Township, Kaohsiung County 840, Taiwan
2School of Pharmacy, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung City 80708, Taiwan
3Graduate Institute of Clinical Pharmacy, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung City 80708, Taiwan

Received 7 June 2013; Accepted 28 July 2013

Academic Editors: A. Concheiro, H. Maibach, and A. Nokhodchi

Copyright © 2013 Pi-Ju Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Blasi, S. Giovagnoli, A. Schoubben et al., “Lipid nanoparticles for brain targeting I. Formulation optimization,” International Journal of Pharmaceutics, vol. 419, no. 1-2, pp. 287–295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Landín, R. C. Rowe, and P. York, “Advantages of neurofuzzy logic against conventional experimental design and statistical analysis in studying and developing direct compression formulations,” European Journal of Pharmaceutical Sciences, vol. 38, no. 4, pp. 325–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Shi, F. Ma, X. Wang, F. Wang, and H. Liao, “Formulation of liposomes gels of paeonol for transdermal drug delivery by Box-Behnken statistical design,” Journal of Liposome Research, vol. 22, no. 4, pp. 270–278, 2012. View at Publisher · View at Google Scholar
  4. B. Subha and M. Muthukumar, “Optimization of ozonation process for the reduction of excess sludge production from activated sludge process of sago industry wastewater using central composite design,” Scientific World Journal, vol. 2012, Article ID 239271, 20122012. View at Publisher · View at Google Scholar
  5. Y.-H. Tsai, L.-T. Fu, C.-T. Huang, J.-S. Chang, Y.-B. Huang, and P.-C. Wu, “Formulation optimization of estradiol microemulsion using response surface methodology,” Journal of Pharmaceutical Sciences, vol. 100, no. 10, pp. 4383–4389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. van ve Ven, M. Vermeersch, A. Matheeussen et al., “PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation,” International Journal of Pharmaceutics, vol. 420, no. 1, pp. 122–132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. S. Villar, B. C. Naveros, A. C. C. Campmany, M. A. Trenchs, C. B. Rocabert, and L. H. Bellowa, “Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil,” International Journal of Pharmaceutics, vol. 431, pp. 161–175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Z. Zhou, R. G. Alany, V. Chuang, and J. Wen, “Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design,” Drug Development and Industrial Pharmacy, vol. 39, no. 2, pp. 321–330, 2013. View at Publisher · View at Google Scholar
  9. G. A. Lewis, D. Mathieu, and R. Phan-Tan-Luu, Pharmaceutical Experimental Design, Dekker, New York, NY, USA, 1999.
  10. G. L. Peck, T. G. Olsen, and F. W. Yoder, “Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid,” The New England Journal of Medicine, vol. 300, no. 7, pp. 329–333, 1979. View at Google Scholar · View at Scopus
  11. J. S. Strauss, “Isotretinoin (Accutane) for the management of severe nodulocystic acne,” Iowa Medicine, vol. 74, no. 4, pp. 170–172, 1984. View at Google Scholar · View at Scopus
  12. J. S. Strauss, R. P. Rapini, A. R. Shalita et al., “Isotretinoin therapy for acne: results of a multicenter dose-response study,” Journal of the American Academy of Dermatology, vol. 10, no. 3, pp. 490–496, 1984. View at Google Scholar · View at Scopus
  13. A. M. Nelson, Z. Cong, K. L. Gilliland, and D. M. Thiboutot, “TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells,” British Journal of Dermatology, vol. 165, no. 3, pp. 526–533, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. R. Lumsden, A. M. Nelson, M. C. Dispenza et al., “Isotretinoin increases skin-surface levels of neutrophil gelatinase-associated lipocalin in patients treated for severe acne,” British Journal of Dermatology, vol. 165, no. 2, pp. 302–310, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. USP 34, U.S.P.C., Rockville, Md, USA, 2011.
  16. H.-O. Ho, L.-C. Chen, H.-M. Lin, and M.-T. Sheu, “Penetration enhancement by menthol combined with a solubilization effect in a mixed solvent system,” Journal of Controlled Release, vol. 51, no. 2-3, pp. 301–311, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. Y.-B. Huang, Y.-H. Tsai, S.-H. Lee, J.-S. Chang, and P.-C. Wu, “Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology,” International Journal of Pharmaceutics, vol. 289, no. 1-2, pp. 87–95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. W. Korsmeyer, R. Gurny, and E. Doelker, “Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: Effect of entrapped air,” Journal of Pharmaceutical Sciences, vol. 72, no. 10, pp. 1189–1191, 1983. View at Google Scholar · View at Scopus
  19. N. A. Peppas, “Analysis of Fickian and non-Fickian drug release from polymers,” Pharmaceutica Acta Helvetiae, vol. 60, no. 4, pp. 110–111, 1985. View at Google Scholar · View at Scopus
  20. V. P. Shah, G. L. Flynn, A. Yacobi et al., “Bioequivalence of topical dermatological dosage forms: methods of evaluation of bioequivalence,” Pharmaceutical Research, vol. 15, no. 2, pp. 167–171, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. FDA, Guidance Fro Industry. Dissolution Testing of Immediate Release Solid Oral Dosage Forms, FDA, Rockville, Md, USA, 1997.
  22. A. H. Kibbe, Handbook of Pharmaceutical Excipients, Pharmaceutical Press, London, UK, 3rd edition, 2000.